Vivakor, Inc. (OTC:VIVK) has announced that it continues to demonstrate independent growth after reporting a strong performance in 2009. It’s R&D Product Pipeline strategy is focused on the concept of licensing and strategic partnering. The project targets commercialization and product specific exit strategies in an effort to increase revenue potential from its new technologies.
MicroCap Insider is a web-based financial portal.
Sign Up for our Free Stock Newsletter
MicroCap Insider publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors.
A research company, Vivakor develops products for the molecular medicine, electro-optics, biological handling and natural and formulary compounds fields. The company also offers contract research services for third parties. It’s four primary areas of operation are Molecular Medicine, Electro-Optics, Biological Handling and Natural and Formulary Products.
Sign Up for FREE. Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website.
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer.
